A 58-year-old client with type 2 diabetes mellitus is scheduled for fluorescein angiography to assess for diabetic retinopathy progression. Which instruction should the nurse provide to the client before the procedure?
A 58-year-old client with type 2 diabetes mellitus is scheduled for fluorescein angiography to assess for diabetic retinopathy progression.
1Remove all jewelry and metal objects before the procedure
2Fast for 12 hours prior to the examination
3Inform the healthcare provider of any allergies, especially to iodine or shellfish✓ 정답
4Avoid looking at bright lights for 24 hours before the test
해설
Informing about allergies, especially to iodine or shellfish, is crucial due to risk of allergic reactions to fluorescein dye. Other instructions like fasting or avoiding bright lights are not typically required.
Core Nursing ExplanationKey Concept Analysis: This question assesses your knowledge of pre-procedure patient education for Fluorescein Angiography, a diagnostic test for Diabetic Retinopathy. The core theme is patient safety, specifically identifying and preventing potential allergic reactions to the contrast dye used in the procedure. The pathophysiology link is that diabetic retinopathy involves damage to the retinal blood vessels, and this test uses an intravenous dye to visualize them, which carries a risk of hypersensitivity.
Answer Rationale: Key Point! The correct answer is to inform the healthcare provider of any allergies, especially to iodine or shellfish. While fluorescein dye is not iodine-based, this instruction is a standard and critical safety screening question. It prompts the patient to disclose any history of allergic reactions, which is essential because fluorescein sodium can cause severe reactions, including anaphylaxis. The nurse must assess for any allergy history before administering any contrast agent.
Distractor Analysis:
Watch out for confusion! Option ① (Remove jewelry) is common for procedures like MRI (Magnetic Resonance Imaging) but is not a standard or necessary precaution for fluorescein angiography, which does not involve strong magnetic fields.
Option ② (Fast for 12 hours) is incorrect. Fluorescein angiography does not require fasting. In fact, for a diabetic patient, prolonged fasting could lead to Hypoglycemia, which is a significant safety risk.
Option ④ (Avoid bright lights) is a post-procedure instruction, not a pre-procedure one. After the test, patients may experience temporary visual disturbances and photosensitivity; they are often advised to wear sunglasses and avoid bright lights for a few hours.
Related Concepts: The nurse's role includes thorough patient assessment and education to prevent complications. For any procedure involving contrast media, allergy assessment is paramount. Diabetic patients require specific considerations to maintain glycemic control during diagnostic testing.
Concept Summary
Concept
Key Points
Fluorescein Angiography
Diagnostic eye test. IV injection of fluorescein dye to photograph retinal circulation. Assesses for diabetic retinopathy, macular edema, vascular abnormalities.
Diabetic Retinopathy
Microvascular complication of diabetes. Damaged retinal blood vessels can leak, hemorrhage, or cause neovascularization. Leading cause of blindness in adults.
1. Monitor for allergic reaction. 2. Advise on temporary side effects (yellow vision, photosensitivity). 3. Ensure safe transportation (vision may be blurry).
Side-by-Side Comparison!
Procedure
Key Pre-procedure Instruction
Rationale & Common Confusion
Fluorescein Angiography
Report allergies (any).
Prevents anaphylaxis from dye. Not iodine-based, but allergy screening is universal.
CT Scan with Iodinated Contrast
Report iodine/shellfish allergies. Check renal function (Creatinine/BUN).
Prevents reaction to iodine and contrast-induced nephropathy. Often requires fasting.
MRI with Gadolinium Contrast
Remove all metal. Report kidney disease (GFR).
Prevents projectile injury and NSF (Nephrogenic Systemic Fibrosis). No iodine allergy link.
Anatomy, Physiology & Pharmacology Points
Retina: The light-sensitive layer at the back of the eye. Diabetic retinopathy damages its delicate blood vessels.
Fluorescein Sodium: The injectable dye. It binds to plasma proteins and fluoresces under blue light, highlighting retinal vasculature. Side effects: Nausea, vomiting, urticaria, anaphylaxis (rare). It is excreted unchanged in urine, causing bright yellow discoloration for 24-48 hours.
Pathophysiology Link: Chronic hyperglycemia → damage to capillary endothelial cells in retina → leakage (non-proliferative retinopathy) or abnormal new vessel growth (proliferative retinopathy) → vision loss.
Memory Tips
F-L-U-O-R for Fluorescein Safety: Find Allergy history, Look out for yellow urine (post-procedure), Understand no fasting, Orient to temporary vision changes, Report nausea (common side effect).
Think: "See the vessels, check for allergies!" The dye lets you "see" the retinal vessels, so you must first "check" for allergies to keep the patient safe.
High-Frequency NCLEX Topics
NCLEX frequently tests on patient safety and pre-procedure preparation. For any test involving contrast dye, the #1 priority is assessing for allergies and renal function when applicable. Diabetic patient care is also a high-yield area, so integrating disease management (avoiding hypoglycemia from unnecessary fasting) with procedure prep is key.
Watch Out for Question Variations!
Shift from "What to teach before?" to "What is the priority action if a patient develops urticaria and wheezing during the procedure?" (Answer: Stop the dye infusion, notify the provider, prepare epinephrine and emergency equipment).
Shift to post-procedure care: "A client calls the clinic 6 hours after fluorescein angiography reporting yellow vision. What is the nurse's best response?" (Answer: Reassure the client that this is a normal, temporary side effect of the dye).
Nursing Clinical Practice GuideClinical Scenario: Mr. Chen, a 58-year-old with type 2 diabetes (HbA1c 8.5%), arrives at the ophthalmology clinic for his scheduled fluorescein angiogram. He mentions he had a "bad reaction" to a CT scan dye years ago but isn't sure what it was.
Nursing Intervention Strategy:
Assessment: Before the procedure, take a focused history. Ask specifically: "Have you ever had an allergic reaction to any medication, dye, or iodine? Do you have allergies to shellfish? Have you ever had a reaction during an X-ray or scan?" Document the response in detail. Assess current medications, especially metformin (may need to be held if renal impairment is suspected with other contrast types, but not typically for fluorescein). Check blood glucose to ensure he is not hypoglycemic from fasting.
Nursing Diagnosis: Risk for allergic reaction related to administration of fluorescein dye. Risk for injury related to temporary visual disturbance post-procedure.
Planning & Implementation:
Communicate any allergy history clearly to the ophthalmologist or technician performing the procedure.
Ensure emergency equipment (crash cart with epinephrine, diphenhydramine, albuterol) is accessible in the clinic.
Provide clear education: "You will feel a quick pinch from the IV. The dye will make your skin look slightly yellow and your urine bright yellow for a day or two. You might feel nauseous for a minute; tell us if you do. After the test, your vision may be blurry and sensitive to light. Wear sunglasses and have someone drive you home."
Do not advise fasting. Encourage the patient to eat normally and take his diabetes medications as prescribed to avoid blood sugar swings.
Evaluation: Monitor the patient during and for 20-30 minutes after the injection for signs of reaction (itching, hives, dyspnea, hypotension). Confirm he understands post-procedure instructions and has a safe ride home.
Patient Safety and Precautions: The major precaution is allergy screening. Although severe reactions are rare, they are possible. Have IV access established. Contraindications include known hypersensitivity to fluorescein sodium. Use with caution in patients with asthma or a history of multiple allergies.
Nursing Procedure & Medication FlowProcedure Steps (Nurse's Role):
1. Verify patient identity and informed consent.
2. Perform allergy assessment (as above).
3. Establish IV access (usually in antecubital fossa).
4. Position patient comfortably at the fundus camera.
5. The provider will inject the dye rapidly (3-5 mL of 10% solution).
6. Monitor closely during injection: Observe for extravasation (dye leakage into tissues) and systemic reactions.
7. Post-procedure: Remove IV, apply pressure. Provide discharge instructions.
Medication Point: Fluorescein sodium. Not a drug for treatment, but a diagnostic agent. No specific antidote for reaction—treatment is supportive (antihistamines, corticosteroids, epinephrine for anaphylaxis).
A Word from Your Senior Nurse
"In the clinic or hospital, you are the patient's advocate and safety officer. For a simple-sounding test like this, a thorough allergy check is what stands between a routine procedure and a life-threatening emergency. Always double-check. And with diabetic patients, always think about their whole health—don't let pre-procedure instructions disrupt their glycemic control. Your attention to these details embodies true patient-centered care and will be reflected in both your NCLEX success and your clinical excellence."
Fluorescein Angiography — A diagnostic procedure where fluorescein dye is injected intravenously to photograph the circulation of blood in the retina and choroid. Used to evaluate diabetic retinopathy, macular degeneration, and other retinal disorders.
Diabetic Retinopathy — A diabetes complication that affects the eyes, caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). It can progress from non-proliferative (mild) to proliferative (severe) stages.
Anaphylaxis — A severe, life-threatening allergic reaction that can occur rapidly after exposure to an allergen. Symptoms include difficulty breathing, swelling, hives, and hypotension. It is a medical emergency requiring immediate epinephrine.
Informed Consent — The process of communication between a patient and provider that results in the patient's authorization or agreement to undergo a specific medical intervention. It requires disclosure, comprehension, and voluntariness.
Hypoglycemia — A condition characterized by an abnormally low level of blood glucose (typically <70 mg/dL). Symptoms include shakiness, sweating, confusion, and irritability. A critical concern for diabetic patients, especially when fasting is incorrectly advised.